Anjali Mehta, MD
Otolaryngology · Worcester, MANPI 1043343429
Payments from drug & device makers
Across 29 payments — averaging $24.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$134
- AstraZeneca$113
- Intersect ENT, Inc.$94
- Novartis$69
- Seagen Inc.$55
- Sobi, Inc$33
- plus $209 from 9 others
What the payments were for
- Consulting fees$7511%
- Food & beverage$63189%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 6 | $134 |
| AstraZeneca | 4 | $113 |
| Intersect ENT, Inc. | 2 | $94 |
| Novartis | 4 | $69 |
| Seagen Inc. | 2 | $55 |
| Sobi, Inc | 1 | $33 |
| Johnson & Johnson | 1 | $31 |
| Karyopharm Therapeutics Inc. | 1 | $29 |
| Beigene USA, Inc. | 1 | $28 |
| Smith+Nephew | 1 | $27 |
| Eisai Inc. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Optinose US, Inc. | 1 | $18 |
| Stryker | 1 | $16 |
| Ambu Inc. | 2 | $12 |
How this compares
$706 in reported general payments places this provider in the 50th percentile of 298 otolaryngology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Wixela InhubFluticasone Propion/Salmeterol | 13 | $2,294 |
| Epinephrine | 13 | $2,225 |
| Mometasone Furoate | 27 | $1,744 |
| Ofloxacin | 30 | $1,599 |
| Fluocinolone Acetonide Oil | 27 | $1,461 |
| Azelastine Hcl | 48 | $1,276 |
| Ipratropium Bromide | 42 | $1,191 |
| Fluticasone Propionate | 57 | $1,006 |
| Omeprazole | 45 | $673 |
| Cefpodoxime Proxetil | 12 | $519 |
| Levocetirizine Dihydrochloride | 16 | $351 |
| Montelukast Sodium | 18 | $307 |
| Famotidine | 15 | $228 |
| Methylprednisolone | 37 | $216 |
| Prednisone | 29 | $87 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Worcester
- Min AhnWorcester$22K
- Divya ChariWorcester$11K
- Christopher ItoWorcester$9K
- Ricardo AuletWorcester$7K
- Jason KassWorcester$4K
- Allan GoldsteinBoston$962K
- Michael PlattBoston$753K
- Avner AliphasNewton$735K
- Christopher BrookBoston$734K
- Gregory RandolphBoston$550K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.